Attitudes Towards PrEP and Anticipated Condom Use Among Concordant HIV-Negative and HIV-Discordant Male Couples

Since the July 2012 approval by the FDA of emtricitabine/ tenofovir disoproxil fumarate (Truvada) for use as pre-exposure prophylaxis (PrEP) against HIV, its feasibility and acceptability has been under study. HIV-discordant couples are likely targets for PrEP but little is known about how this new...

Full description

Saved in:
Bibliographic Details
Published in:AIDS Patient Care STDS
Main Authors: Hoff, Colleen C., Chakravarty, Deepalika, Bircher, Anja E., Campbell, Chadwick K., Grisham, Kirk, Neilands, Torsten B., Wilson, Patrick A., Dworkin, Shari
Format: Artigo
Language:Inglês
Published: Mary Ann Liebert, Inc. 2015
Subjects:
Behavioral and Psychosocial Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4504342/
https://ncbi.nlm.nih.gov/pubmed/26057304
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/apc.2014.0315
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items